These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25457058)

  • 1. Recanalized thrombus treated with bioresorbable vascular scaffold: insights from optical coherence tomography.
    Gómez-Monterrosas O; Regueiro A; Santos A; Otsuki S; Scalone G; Fernández-Rodríguez D; Sabaté M
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1453-5. PubMed ID: 25457058
    [No Abstract]   [Full Text] [Related]  

  • 2. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.
    Karanasos A; Garcia-Garcia HM; van Geuns RJ; Regar E
    JACC Cardiovasc Interv; 2015 Mar; 8(3):e53-e54. PubMed ID: 25790767
    [No Abstract]   [Full Text] [Related]  

  • 3. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable vascular scaffold for ST elevation myocardial infarction: optical coherence tomography observations at the 2-year follow-up.
    Fam JM; Karanasos A; Regar E; van Geuns RJ
    Coron Artery Dis; 2015 Sep; 26(6):545-7. PubMed ID: 25919904
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
    Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: Optical coherence tomography evaluation and clinical outcomes.
    Kochman J; Tomaniak M; Pietrasik A; Kołtowski Ł; Rdzanek A; Huczek Z; Mazurek T; Jąkała J; Ząbek A; Legutko J; Kochman W; Filipiak KJ
    Cardiol J; 2015; 22(3):315-22. PubMed ID: 25428734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Unusual Complication After Bioresorbable Scaffold Implantation: Visualization of Intramural Hematoma by Optical Coherence Tomography.
    Zhang BC; Karanasos A; Royaards KJ; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2015 Aug; 8(9):e143-e145. PubMed ID: 26292606
    [No Abstract]   [Full Text] [Related]  

  • 8. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side branch occlusion after bioresorbable vascular scaffold implantation: lessons from optimal coherence tomography.
    Sato K; Panoulas VF; Kawamoto H; Naganuma T; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):116-8. PubMed ID: 25616826
    [No Abstract]   [Full Text] [Related]  

  • 10. DESolve novolimus-eluting bioresorbable coronary scaffold failure assessed by frequency-domain optical coherence tomography imaging.
    Porto I; Vergallo R; Sangiorgi GM; Burzotta F; Garbo R; D'Amario D; Trani C; Rebuzzi AG; Crea F
    Coron Artery Dis; 2016 Jun; 27(4):334-6. PubMed ID: 26882020
    [No Abstract]   [Full Text] [Related]  

  • 11. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recanalized Thrombus Treated With a Paclitaxel-Coated Balloon: Insights from Optical Coherence Tomography.
    Watanabe Y; Fujino Y; Ishiguro H; Nakamura S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):618-20. PubMed ID: 27013163
    [No Abstract]   [Full Text] [Related]  

  • 13. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Comparison of a Bioresorbable Vascular Scaffold by High-Frequency Intravascular Ultrasound and Optical Coherence Tomography.
    Shan P; Motivala A; Moses J; Maehara A; Mintz GS; Ali ZA
    JACC Cardiovasc Interv; 2015 Sep; 8(11):e187-e188. PubMed ID: 26404210
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial assessment of bioresorbable-polymer sirolimus-eluting stent by coronary angioscopy and optical coherence tomography.
    Nakamura S; Kimura S; Nakagama S; Hayashi Y; Yamamoto T; Utsugi Y; Doi J; Mizusawa M; Araki M; Sudo Y; Hishikari K; Hikita H; Takahashi A; Isobe M
    Coron Artery Dis; 2017 Sep; 28(6):530-531. PubMed ID: 28402989
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold.
    Wiebe J; Möllmann H; Most A; Dörr O; Weipert K; Rixe J; Liebetrau C; Elsässer A; Achenbach S; Hamm C; Nef H
    Clin Res Cardiol; 2014 Feb; 103(2):141-8. PubMed ID: 24136291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities.
    Simsek C; Karanasos A; Magro M; Garcia-Garcia HM; Onuma Y; Regar E; Boersma E; Serruys PW; van Geuns RJ
    EuroIntervention; 2016 Jan; 11(9):996-1003. PubMed ID: 25349042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding light on scaffold vascular response.
    Gogas BD; Samady H
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1370-3. PubMed ID: 25523530
    [No Abstract]   [Full Text] [Related]  

  • 20. Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.
    Koltowski L; Tomaniak M; Ochijewicz D; Maksym J; Roleder T; Zaleska M; Proniewska K; Opolski G; Kochman J
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):E1-E7. PubMed ID: 31343827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.